{"id":"exacyl","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolic events (deep vein thrombosis, pulmonary embolism)"},{"rate":null,"effect":"Gastrointestinal disturbances (nausea, vomiting, diarrhea)"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Visual disturbances"}]},"_chembl":{"chemblId":"CHEMBL877","moleculeType":"Small molecule","molecularWeight":"157.21"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tranexamic acid is a competitive inhibitor of plasminogen and plasmin, which are key enzymes in the fibrinolytic cascade responsible for breaking down blood clots. By preventing the conversion of plasminogen to plasmin, the drug stabilizes fibrin clots and reduces fibrin degradation, making it effective for controlling bleeding in various clinical settings.","oneSentence":"Exacyl (tranexamic acid) inhibits fibrinolysis by blocking plasminogen activation, thereby reducing excessive bleeding.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:11:51.610Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of hemorrhage in surgical patients"},{"name":"Management of heavy menstrual bleeding"},{"name":"Hemophilia and other bleeding disorders"}]},"trialDetails":[{"nctId":"NCT04448184","phase":"PHASE3","title":"Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-02-16","conditions":"Hematologic Neoplasms","enrollment":662},{"nctId":"NCT05978180","phase":"NA","title":"Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2)","status":"COMPLETED","sponsor":"Labrha","startDate":"2023-10-18","conditions":"Knee Osteoarthritis","enrollment":252},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT07261930","phase":"PHASE4","title":"Effectiveness of Tranexamic Acid in Reducing Blood Loss During Femoral Nail Surgery","status":"COMPLETED","sponsor":"Masaka Regional Referral Hospital","startDate":"2018-10-01","conditions":"Femoral Fractures, Hemorrhage, Surgical, Tranexamic Acid Use","enrollment":43},{"nctId":"NCT03136445","phase":"PHASE3","title":"TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia","status":"COMPLETED","sponsor":"NHS Blood and Transplant","startDate":"2015-06","conditions":"Hematologic Neoplasms, Hemorrhage, Hematopoietic Stem Cell Transplantation","enrollment":616},{"nctId":"NCT07034560","phase":"PHASE4","title":"Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thammasat University","startDate":"2024-11-12","conditions":"Melasma, Treatment Outcome, Recurrence","enrollment":75},{"nctId":"NCT02314988","phase":"PHASE2, PHASE3","title":"Tranexamic Acid to Reduce Blood Loss in Spine Surgery","status":"RECRUITING","sponsor":"Columbia University","startDate":"2020-06-15","conditions":"Spinal Injuries, Spinal Deformity","enrollment":252},{"nctId":"NCT04625530","phase":"PHASE3","title":"Perioperative Management in Gynaecological Carcinoma Surgery","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-01","conditions":"Gynaecological Carcinoma","enrollment":""},{"nctId":"NCT04410042","phase":"PHASE3","title":"Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2021-01-29","conditions":"Cancer of the Bone, Limb Salvage","enrollment":15},{"nctId":"NCT06010368","phase":"PHASE3","title":"Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Cesarean Section Complications, Tranexamic Acid, Oxytocin","enrollment":150},{"nctId":"NCT06516419","phase":"NA","title":"Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy","status":"RECRUITING","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2024-02-13","conditions":"Melasma","enrollment":90},{"nctId":"NCT06490653","phase":"PHASE4","title":"Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management","status":"NOT_YET_RECRUITING","sponsor":"Ankara Ataturk Sanatorium Training and Research Hospital","startDate":"2024-10","conditions":"Epistaxis Nosebleed","enrollment":186},{"nctId":"NCT02606045","phase":"PHASE3","title":"Minimize Menorrhagia in Women With Von Willebrand Disease","status":"TERMINATED","sponsor":"Margaret Ragni","startDate":"2019-02-07","conditions":"Von Willebrand Diseases","enrollment":39},{"nctId":"NCT06452342","phase":"PHASE4","title":"TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06","conditions":"Venous Thromboembolism, Venous Thromboses, Heavy Menstrual Bleeding","enrollment":20},{"nctId":"NCT05024253","phase":"PHASE3","title":"Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.","status":"COMPLETED","sponsor":"Children's Cancer Hospital Egypt 57357","startDate":"2021-08-02","conditions":"Ewing Sarcoma of Bone, Osteosarcoma","enrollment":48},{"nctId":"NCT05382403","phase":"NA","title":"Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-10-23","conditions":"Postpartum Hemorrhage, Maternal Death","enrollment":424},{"nctId":"NCT06091891","phase":"NA","title":"Tranexamic Acid in Pediatric Scoliosis Surgery","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2023-10-16","conditions":"Scoliosis","enrollment":84},{"nctId":"NCT05947435","phase":"NA","title":"Tranexamic Acid in Percutaneous Nephrolithotomy","status":"COMPLETED","sponsor":"Haseki Training and Research Hospital","startDate":"2022-01-01","conditions":"Percutaneous Nephrolithotomy, Intraoperative Use of Tranexamic Acid","enrollment":75},{"nctId":"NCT03897621","phase":"NA","title":"The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2019-05-20","conditions":"Coagulation; Intravascular, Rotational Thromboelastometry, Fibrinolysis; Hemorrhage","enrollment":50},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":"Misoprostol Allergy, Oxytocin Allergy, Tranexamic Acid Allergy","enrollment":105},{"nctId":"NCT05439694","phase":"PHASE4","title":"TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-07-03","conditions":"Rectus Sheath Hematoma, Cesarean Section","enrollment":63},{"nctId":"NCT04696224","phase":"NA","title":"Comparative Use of Tranexamic Acid Intravenous and Topical Application in Intertrochanteric Fractures With PFNA","status":"UNKNOWN","sponsor":"Universidade do Vale do Sapucai","startDate":"2020-12-18","conditions":"Hemorrhage, Fracture Femur","enrollment":90},{"nctId":"NCT04635007","phase":"PHASE3","title":"Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-01-01","conditions":"Cesarean Section Complications, Blood Loss, Surgical, Misoprostol","enrollment":200},{"nctId":"NCT03328832","phase":"PHASE4","title":"Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2017-09-12","conditions":"Osteoarthritis, Knee","enrollment":70},{"nctId":"NCT00500656","phase":"PHASE3","title":"Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)","status":"COMPLETED","sponsor":"Shire","startDate":"2005-03-01","conditions":"Hereditary Angioedema","enrollment":85},{"nctId":"NCT03863964","phase":"EARLY_PHASE1","title":"Tranexamic Acid Pharmacokinetics During Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-06-01","conditions":"Postpartum Hemorrhage","enrollment":20},{"nctId":"NCT02702128","phase":"PHASE3","title":"Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-01-03","conditions":"Peri-operative Hemorrhage or Hematoma, Surgery, Retrognathism","enrollment":157},{"nctId":"NCT02747615","phase":"PHASE4","title":"Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-08","conditions":"Revision Total Hip Arthroplasty (RTHA)","enrollment":60},{"nctId":"NCT03742947","phase":"NA","title":"Haemostasis and Tranexamic Acid in Caesarean Delivery","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2019-01-10","conditions":"Postpartum Hemorrhage, Hyperfibrinolysis","enrollment":34},{"nctId":"NCT03431805","phase":"PHASE3","title":"TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2018-03-03","conditions":"Postpartum Hemorrhage","enrollment":4574},{"nctId":"NCT03623789","phase":"PHASE4","title":"Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-08-15","conditions":"Hip Replacement, Total","enrollment":90},{"nctId":"NCT03364569","phase":"","title":"Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.","status":"COMPLETED","sponsor":"Hôpital NOVO","startDate":"2014-11-01","conditions":"Plastic Surgery","enrollment":40},{"nctId":"NCT02403596","phase":"PHASE3","title":"Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-10-20","conditions":"Blood Loss After a Total Hip Replacement","enrollment":231},{"nctId":"NCT03310060","phase":"PHASE4","title":"Reducing Blood Loss Using Tisseel in TKA","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2017-11-01","conditions":"Total Blood Loss","enrollment":100},{"nctId":"NCT02063035","phase":"PHASE4","title":"Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2012-08","conditions":"Lumbar Spinal Stenosis, Thoracic Spinal Stenosis","enrollment":29},{"nctId":"NCT02153593","phase":"PHASE3","title":"Postoperative Bleeding Prevention in Massive Bone Tumour Resection","status":"TERMINATED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2013-03","conditions":"Blood Loss, Bone Tumour","enrollment":56},{"nctId":"NCT02865174","phase":"PHASE4","title":"Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-09","conditions":"Osteoarthritis, Knee","enrollment":90},{"nctId":"NCT02829346","phase":"PHASE2","title":"Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2012-10","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT02428868","phase":"NA","title":"IV Iron in Association With Tranexamic Acid for Hip Fracture","status":"UNKNOWN","sponsor":"Institut Kassab d'Orthopédie","startDate":"2015-04","conditions":"Hip Fracture, Anemia","enrollment":150},{"nctId":"NCT02152917","phase":"PHASE4","title":"Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-02","conditions":"Knee Osteoarthritis","enrollment":45},{"nctId":"NCT01655641","phase":"PHASE2, PHASE3","title":"Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery","status":"UNKNOWN","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2012-07","conditions":"Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer","enrollment":118}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tranexamic acid"],"phase":"phase_3","status":"active","brandName":"Exacyl®","genericName":"Exacyl®","companyName":"University Hospital, Brest","companyId":"university-hospital-brest","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Exacyl (tranexamic acid) inhibits fibrinolysis by blocking plasminogen activation, thereby reducing excessive bleeding. Used for Prevention and treatment of hemorrhage in surgical patients, Management of heavy menstrual bleeding, Hemophilia and other bleeding disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}